Peptide InjectionsAI
Moderate evidence

Nonapeptide-1

Peptide therapy: benefits, side effects, cost and protocols

C61H87N15O9S

1,206.5 g/mol / CID 10418849
C61H87N15O9S

Nonapeptide-1 is a biomimetic peptide that reduces melanin synthesis by antagonizing alpha-MSH at the MC1 receptor level. It is used in cosmetic formulations as a skin-brightening and tone-evening agent.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Moderate Evidence

Who Nonapeptide-1 is usually considered for

  • Melanin inhibition
  • 1 preclinical study
  • Skin brightening
  • Pigmentation control
  • UV damage protection
  • 1 preclinical study
  • Limited human trials or strong preclinical

How Nonapeptide-1 works

Antagonizes alpha-MSH at the MC1R receptor on melanocytes, reducing cAMP-mediated activation of tyrosinase and downstream melanin synthesis pathways.

Key studies

4 papers on PubMed

  1. 01

    A randomized controlled pilot study of a proprietary combination versus sunscreen in melasma maintenance

    Indian J Dermatol Venereol Leprol / RCT

  2. 02

    Proprietary combination showed efficacy versus sunscreen in melasma maintenance

  3. 03

    Optimization of Dielectric Material Improves Ionization Capability and Mass Range of Dielectric Barrier Discharge Ionization Mass Spectrometry

  4. 04

    Guan X, Wei C, Yan X et al

    In Vitro / J Am Soc Mass Spectrom

  5. 05

    Optimized dielectric material improved ionization and mass range capabilities

  6. 06

    Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging

  7. 07

    Huang ZJ, Zhou XH, Wen WQ et al

    In Vitro / Int J Pharm

  8. 08

    EGCG-loaded nanoparticles enhanced skin benefits and reversed photoaging effects

  9. 09

    Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway

  10. 10

    Chen J, Li H, Liang B et al

    In Vitro / Postepy Dermatol Alergol

Nonapeptide-1 compound data

C61H87N15O9S
1206.5 g/mol
10418849 ↗
(2S)-N-[(1R)-2-[[(1S)-1-[[(1R)-2-[[(1S)-2-[[(1S)-5-amino-1-[(2S)-2-[[(1S)-1-carbamoyl-2-methyl-propyl]carbamoyl]pyrrolidine-1-carbonyl]pentyl]amino]-1-benzyl-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]amino]-1-benzyl-2-oxo-ethyl]-1-[(2S)-2-amino-4-methylsulfanyl-butanoyl]pyrrolidine-2-carboxamide

Nonapeptide-1 questions

What is NONAPEPTIDE-1?

Nonapeptide-1 is a synthetic peptide that inhibits melanin synthesis by blocking alpha-MSH binding to MC1R receptors, used in cosmetic formulations for skin brightening.

How does NONAPEPTIDE-1 work?

Antagonizes alpha-MSH at the MC1R receptor on melanocytes, reducing cAMP-mediated activation of tyrosinase and downstream melanin synthesis pathways.

Is NONAPEPTIDE-1 legal to buy?

NONAPEPTIDE-1 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy NONAPEPTIDE-1?

NONAPEPTIDE-1 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.

What category does NONAPEPTIDE-1 belong to?

NONAPEPTIDE-1 is primarily classified as a skin, hair & cosmetic peptide. Peptides studied for cosmetic applications including skin rejuvenation, collagen production, tanning, hair growth, and anti-wrinkle effects.

What are the research benefits of NONAPEPTIDE-1?

NONAPEPTIDE-1 has been studied for: Melanin inhibition, Skin brightening, Pigmentation control, UV damage protection. Cosmetic peptide; MC1R antagonist for depigmentation. Also known as Melanostatine.

Nonapeptide-1 in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Nonapeptide-1?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz